Delivery Order SPE2DB22D3501-SPE2DB24FUS31
Award Date 2/26/24
Potential Completion Date 2/27/24
Potential Value $18K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $5,105.33 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. This delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The $5,550.74 order has a completion date of February 13, 2024 and was awarded on February 12, 2024. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that enables Amerisourcebergen to deliver a range of pharmaceutical products and medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $7,685.70 by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The order has a completion date of February 5, 2024 and was awarded on February 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for $4,871.64 to provide M-M-R II vaccine vials. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The delivery order has a potential value of $2,996.08 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which does not have a set-aside designation. The company also holds an indefinite delivery contract (IDC) with a potential value of...
- This is a firm fixed price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,186.72 order is for the provision of M-M-R II vaccine vials, with a period of performance through April 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $30,556.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of M-M-R II vaccine vials and has a period of performance through April 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to provide a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,537.14 firm fixed price delivery order contract to provide M-M-R II vaccine vials. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This award is part of Amerisourcebergen's indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,561.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. This order is for the supply of M-M-R II vaccine vials, with an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical in the amount of $1,537.14 to provide M-M-R II vaccine vials. The contract has a completion date of February 27, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUS31Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $17,893.02 by the Defense Logistics Agency (DLA) for the delivery of M-M-R II vaccine vials. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00, to provide a broad range of pharmaceutical products and medical supplies in support of military treatment programs and facilities worldwide. The contract has no set-aside designation.
Generated 6/2/24, 12:21 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 2/26/24 |